Allergy/Imm

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Paramita DK et al. - The IgA EA ELISA is proposed as a confirmation test in first-line NPC serological screening studies. This two-step EBV ELISA system provides a standardized approach for NPC screening and may be used in combination with dried blood sampling in future field studies for identification of early-stage NPC in high-risk regions.

Related Articles

Paclitaxel with cisplatin in concurrent chemoradiotherapy for locally advanced nasopharyngeal carcinoma
European Archives of Oto-Rhino-Laryngology, 10/14/09    Relevance Score: 68%

Incidence of nasopharyngeal carcinoma in Chinese immigrants, compared with Chinese in China and South East Asia: review
The Journal of Laryngology & Otology, 10/06/09    Relevance Score: 68%

Horner Syndrome as a Presenting Sign of Nasopharyngeal Carcinoma
Ophthalmic Plastic and Reconstructive Surgery, 10/07/09    Relevance Score: 67%

Widespread expression of prostate apoptosis response-4 in nasopharyngeal carcinoma
Head & Neck, 11/13/09    Relevance Score: 66%

Preclinical activity of gefitinib in non-keratinizing nasopharyngeal carcinoma cell lines and biomarkers of response
Investigational New Drugs, 10/08/09    Relevance Score: 66%

Today in Diagnostics/Radiology...keeping you current

Application of an ELISA-elution Assay to Dissociate Digoxin-antibody Complexes in Immunoaffinity Chromatography
Scandinavian Journal of Immunology, 12/15/09

Advantages of Multiplex Proteomics in Clinical Immunology
Clinical Reviews in Allergy and Immunology, 12/15/09

Decreased Levels of Secretory Leucoprotease Inhibitor in the Pseudomonas-Infected Cystic Fibrosis Lung Are Due to Neutrophil Elastase Degradation
Journal of Immunology, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address